financetom
Business
financetom
/
Business
/
Protagenic Therapeutics (PTIX) Shares Surge On Clinical Trial Progress
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Protagenic Therapeutics (PTIX) Shares Surge On Clinical Trial Progress
Aug 21, 2025 1:01 PM

Shares of Protagenic Therapeutics Inc ( PTIX ) are trading sharply higher Thursday afternoon, soaring over 100% midday after the company announced a key clinical milestone.

What To Know: This morning, the biopharmaceutical firm reported the successful administration of the first dose to all subjects in the multiple-dose portion of its ongoing Phase 1 clinical trial for PT00114. This investigational hormone therapy is being developed to treat stress and mood disorders, including anxiety, depression, and PTSD.

Protagenic expects to complete dosing by the end of August and anticipates releasing topline safety data by the end of September. The company stated that this progress keeps it on track to initiate a Phase 2 efficacy trial in the first quarter of 2026.

The company says PT00114 is based on a naturally occurring brain hormone, Teneurin C-terminus Associated Peptide, which regulates stress and emotional balance. PT00114 is designed to modulate the brain’s maladaptive responses to stress, potentially offering a differentiated approach with fewer side effects.

Price Action: According to data from Benzinga Pro, PTIX shares are trading higher by 76% to $4.02 Thursday afternoon. The stock has a 52-week high of $15.54 and a 52-week low of $2.25.

Read Also: CVS Health Declines To Add Gilead’s Steeply Priced New HIV Prevention Drug To Its Plans

How To Buy PTIX Stock

By now you're likely curious about how to participate in the market for Protagenic Therapeutics ( PTIX ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Slm Insider Sold Shares Worth $1,949,023, According to a Recent SEC Filing
Slm Insider Sold Shares Worth $1,949,023, According to a Recent SEC Filing
Mar 4, 2024
05:32 PM EST, 03/04/2024 (MT Newswires) -- Jonathan Boyles, Senior Vice President & Controller, on February 29, 2024, sold 94,078 shares in Slm (SLM) for $1,949,023. Following the Form 4 filing with the SEC, Boyles has control over a total of 52,751 shares of the company, with 52,751 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1032033/000162828024008587/xslF345X03/wk-form4_1709591227.xml Price: 20.66, Change: -0.36, Percent Change:...
Iqvia Holdings Insider Sold Shares Worth $3,494,034, According to a Recent SEC Filing
Iqvia Holdings Insider Sold Shares Worth $3,494,034, According to a Recent SEC Filing
Mar 4, 2024
05:32 PM EST, 03/04/2024 (MT Newswires) -- W Richard Staub, President, Research & Development Solutions, on February 29, 2024, sold 14,100 shares in Iqvia Holdings ( IQV ) for $3,494,034. Following the Form 4 filing with the SEC, Staub has control over a total of 15,945 shares of the company, with 15,945 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1478242/000147824224000057/xslF345X03/wk-form4_1709591202.xml Price: 251.81,...
Third Coast Bancshares Appoints Chief Risk and Operations Officer, Chief Legal Officer
Third Coast Bancshares Appoints Chief Risk and Operations Officer, Chief Legal Officer
Mar 4, 2024
05:32 PM EST, 03/04/2024 (MT Newswires) -- Third Coast Bancshares ( TCBX ) said late Monday it named Vicki Alexander as chief risk and operations officer and Liz Eber as chief legal officer, effective Friday. Alexander joined the company as chief compliance and risk officer in September 2022, while Eber joined as head of legal in January 2023. ...
Talos Energy Completes QuarterNorth Energy Acquisition
Talos Energy Completes QuarterNorth Energy Acquisition
Mar 4, 2024
05:32 PM EST, 03/04/2024 (MT Newswires) -- Talos Energy ( TALO ) said late Monday it has completed the acquisition of QuarterNorth Energy. Talos said it has appointed QuarterNorth's designee, Joseph Mills, to its board and plans to update its 2024 operational and financial guidance in the next few days to reflect the acquisition closing time. Price: 12.95, Change: -0.3,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved